Skip to main content

HomeResearchCompareDavunetide vs Pinealon

Peptide Comparison

Davunetide vs Pinealon

Both are Neuro & Cognitive peptides.

Davunetide

NAP

CognitiveInvestigationalResearch Only

No providers listed yet

Full Davunetide profile →
vs

Pinealon

EDR tripeptide

CognitiveNot EvaluatedResearch Only

Half-life: Unknown

27 providers listed

Full Pinealon profile →
Bottom line

Davunetide carries stronger published evidence (RCT, 3 key studies) than Pinealon (In vitro, 1); both are research compounds.

Quick Verdict

Davunetide

Pinealon

Which One Should You Choose?
Your goalBetter option
Stronger clinical evidenceDavunetide
Further along in FDA reviewDavunetide
More provider options (0 vs 27)Pinealon

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison
Davunetide
Pinealon
Mechanism Family
Neuro & Cognitive
Neuro & Cognitive
Half-life
Unknown
FDA Status
investigational
not evaluated
Admin Routes
intranasal, subcutaneous
intranasal, subcutaneous
Availability
Research Only
Research Only
Providers
None listed
27 listed
Avail. Notes
Russian peptide bioregulator (Glu-Asp-Arg) from pineal gland, Khavinson Institute. Studied for visual function and longevity. No FDA approval, no NDA or IND. Research chemical in US.
Research Evidence

Davunetide

RCT · 3 key studies · most recent 2026

Pinealon

In vitro · 1 key study · most recent 2017
Research Citations

About Davunetide

Stabilizes microtubules by interacting with tubulin and microtubule-associated proteins. Activates SIRT1, reduces amyloid-β toxicity, and enhances synaptic plasticity. Protects against tau hyperphosphorylation.

Research Areas
neuroprotectiontau stabilizationcognitive enhancementmemorysynaptic plasticity

About Pinealon

Glu-Asp-Arg tripeptide; penetrates blood-brain barrier; modulates gene expression in neurons; reduces oxidative stress in brain tissue

Research Areas
neuroprotectionantioxidant (CNS)sleep improvementanti-aging (brain)
Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Davunetide

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Pinealon

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Price (per mg)

Davunetide

Not enough vendor pricing yet.

Pinealon

$3.51/mg

$2.99$4.49 range

38 vendors

Find Providers

Where to source these peptides

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Neuro & Cognitive Comparisons

Browse all peptides →

Educational research tools — not medical advice.

Cite this page

Data last updated August 26, 2026

Free to reference and republish with attribution to PeptideBase. Choose a format:

PeptideBase. (2026). Davunetide vs Pinealon — Per-mg Price Comparison. Retrieved September 11, 2026, from https://peptidebase.io/peptides/compare/davunetide/pinealon

Free newsletter

The Peptide Research Digest

Weekly analysis on providers, sourcing and compounds — from the team behind PeptideBase.

No spam. Unsubscribe anytime. Privacy policy.